EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 220.49M | 180.36M | 154.59M | 175.66M | 160.04M | 355.18M | 329.25M | 324.25M |
流動資産合計 | 192.1M | 172.81M | 146.06M | 167.12M | 150.16M | 344.8M | 317.71M | 294.93M |
現金および同等物 | 75.36M | 95.63M | 105.77M | 139.6M | 133.04M | 281.26M | 271.01M | 90.77M |
非流動資産合計 | 28.39M | 8.91M | 8.54M | 8.54M | 9.88M | 15.64M | 11.54M | 29.32M |
負債合計 | 84.14M | 83.99M | 76.2M | 118.39M | 101.42M | 88.86M | 79.31M | 95.94M |
流動負債合計 | 34.26M | 34.54M | 27.24M | 68.92M | 63.9M | 63.26M | 62.58M | 62.1M |
非流動負債合計 | 79.14M | 78.76M | 78.33M | 49.48M | 37.53M | 25.6M | 16.73M | 33.84M |
普通株 | 34k | 34k | 34k | 34k | 35k | 49k | 50k | 52k |
留保所得 | -627.9M | -671.35M | -692.52M | -715.44M | -728.05M | -742.15M | -771.43M | -802.26M |
年末 2023年12月31日 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 18.68M | 71.67M | 78.17M | 72.97M | 91.72M | 263.37M | 180.36M | 355.18M |
流動資産合計 | 17.74M | 39.91M | 47.6M | 41.72M | 63.12M | 237.75M | 172.81M | 344.8M |
現金および同等物 | 16.9M | 38.78M | 45.26M | 22.21M | 44.91M | 178.59M | 95.63M | 281.26M |
非流動資産合計 | 13.34M | 11.69M | 37.63M | 8.33M | 18.54M | 184.38M | 96.37M | 266.32M |
負債合計 | 5.34M | 59.98M | 40.54M | 64.64M | 73.18M | 78.99M | 83.99M | 88.86M |
流動負債合計 | 5.29M | 21.66M | 21.46M | 11.52M | 14.89M | 23.66M | 34.54M | 63.26M |
非流動負債合計 | 51k | 55.63M | 36.7M | 100.34M | 96.34M | 91.93M | 78.76M | 25.6M |
総資本 | 13.34M | 11.69M | 37.63M | 8.33M | 18.54M | 184.38M | 96.37M | 266.32M |
普通株 | 39k | 74k | 95k | 109k | 18k | 34k | 34k | 49k |
留保所得 | -310.82M | -363.99M | -408.49M | -465.29M | -510.68M | -569.1M | -671.35M | -742.15M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約